DHRS4L2: A Potential Drug Target and Biomarker (G317749)

Target Name: DHRS4L2

NCBI ID: G317749

DHRS4L2

Other Name(s): dehydrogenase/reductase (SDR family) member 4 like 2 | Dehydrogenase/reductase SDR family member 4-like 2 precursor (isoform 1) | NADPH-dependent retinol dehydrogenase/reductase-like protein 2 | short chain dehydrogenase/reductase family 25C member 3 | Short chain dehydrogenase/reductase family 25C member 3 | NADP(H)-dependent retinol dehydrogenase/reductase short isoform-like protein | Dehydrogenase/reductase SDR family member 4-like 2 | Dehydrogenase/reductase SDR family member 4-like 2 precursor | Dehydrogenase/reductase (SDR family) member 4 like 2A3 | DHRS4L2 variant 1 | Short chain dehydrogenase/reductase family 25C, member 3 | Dehydrogenase/reductase (SDR family) member 4 like 2, transcript variant 1 | dehydrogenase/reductase 4 like 2 | dehydrogenase/reductase (SDR family) member 4 like 2A3 | DR4L2_HUMAN | SDR25C3

DHRS4L2: A Potential Drug Target and Biomarker

The dehydrogenase/reductase (SDR) family is a large gene family that includes over 300 known proteins. One of the members of this family is DHRS4L2, which is a protein that has been identified as a potential drug target and biomarker.

DHRS4L2 is a non-coding RNA molecule that is expressed in various tissues and cells, including the brain, heart, and gastrointestinal tract. It is a member of the SDR family and is involved in the detoxification of xenobiotics, such as drugs and other harmful substances, by the body's natural defense mechanisms.

The SDR family is a superfamily of proteins that are involved in the detoxification of a wide variety of xenobiotics. The SDRs are a group of enzymes that are involved in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to a variety of diseases, including cancer, neurodegenerative diseases, and aging. The SDRs are also involved in the detoxification of xenobiotics, which can be harmful to the body.

DHRS4L2 is a member of the SDR family that is involved in the detoxification of xenobiotics. It is a small protein that is expressed in various tissues and cells, including the brain, heart, and gastrointestinal tract. It is involved in the detoxification of a wide variety of xenobiotics, including drugs and other harmful substances.

One of the unique features of DHRS4L2 is its expression pattern. It is primarily expressed in the brain and testes, and is not detected in other tissues. This is important because it suggests that DHRS4L2 may be involved in the detoxification of drugs that are harmful to the brain and testes.

DHRS4L2 is also involved in the detoxification of other xenobiotics that are harmful to the body, including toxins from environmental pollutants and certain medications. It is part of a complex system of detoxification that involves the production of reactive oxygen species, which can damage cellular components and contribute to a variety of diseases.

DHRS4L2 is also a potential biomarker for a variety of diseases. Its expression pattern in the brain and testes suggests that it may be involved in the development and progression of certain neurological and psychiatric disorders. It is also involved in the detoxification of certain drugs that are commonly used to treat these disorders, which may indicate that it may be a potential drug target.

In conclusion, DHRS4L2 is a protein that is involved in the detoxification of xenobiotics and may be a potential drug target and biomarker. Its expression pattern in the brain and testes suggests that it may be involved in the development and progression of certain neurological and psychiatric disorders, and its involvement in the detoxification of certain drugs that are commonly used to treat these disorders may indicate that it could be a useful target for new therapies. Further research is needed to fully understand the role of DHRS4L2 in the detoxification of xenobiotics and its potential as a drug target and biomarker.

Protein Name: Dehydrogenase/reductase 4 Like 2

Functions: Probable oxidoreductase

The "DHRS4L2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DHRS4L2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets